GlucoTrack, Inc., (GCTK): Price and Financial Metrics

GlucoTrack, Inc., (GCTK): $0.43

0.02 (+6.11%)

POWR Rating

Component Grades

Momentum

NR

Stability

NR

Sentiment

Quality

NR

Add GCTK to Watchlist
Sign Up

Industry: Medical - Devices & Equipment

Industry

NR

Ranked

#NR of NR

in industry

GCTK Price/Volume Stats

Current price $0.43 52-week high $3.75
Prev. close $0.40 52-week low $0.21
Day low $0.40 Volume 277,400
Day high $0.44 Avg. volume 1,906,978
50-day MA $0.65 Dividend yield N/A
200-day MA $1.48 Market Cap 8.88M

GCTK Stock Price Chart Interactive Chart >


GlucoTrack, Inc., (GCTK) Company Bio


GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.


GCTK Latest News Stream


Event/Time News Detail
Loading, please wait...

GCTK Latest Social Stream


Loading social stream, please wait...

View Full GCTK Social Stream

Latest GCTK News From Around the Web

Below are the latest news stories about GLUCOTRACK INC that investors may wish to consider to help them evaluate GCTK as an investment opportunity.

Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK)

Aegis Capital Corp. acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ:GCTK).

Yahoo | April 17, 2023

GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock

Rutherford, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced the closing of a firm commitment underwritten public offering of shares of its common stock with gross proceeds to the Company expected to be approximately $10.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The offering consist

Yahoo | April 17, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time for another dive into the biggest pre-market stock movers with all the latest news traders need to know about for Friday!

William White on InvestorPlace | April 14, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another dive into the biggest pre-market stock movers as we see what's moving the market on Thursday morning!

William White on InvestorPlace | April 13, 2023

Why Is GlucoTrack (GCTK) Stock Down 36% Today?

GlucoTrack (GCTK) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering.

William White on InvestorPlace | April 13, 2023

Read More 'GCTK' Stories Here

GCTK Price Returns

1-mo -14.00%
3-mo -59.08%
6-mo N/A
1-year N/A
3-year N/A
5-year -98.35%
YTD -69.50%
2022 -66.19%
2021 -9.64%
2020 N/A
2019 N/A
2018 0.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!